Market Outlook
The global Crude Heparin market size was valued at USD 3855.8 million in 2022 and is forecast to a readjusted size of USD 6135.8 million by 2029 with a CAGR of 6.9% during review period.
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, etc. The top three players hold a share about 37%. The global crude heparin products are mainly produced in Europe and China, they occupied for a share over 50%. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately.
This report is a detailed and comprehensive analysis for global Crude Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Crude Heparin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Crude Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Crude Heparin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Crude Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Crude Heparin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Crude Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Segmentation By Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Segmentation By Application
UFH
LMWH
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the crude heparin market in 2025?
The crude heparin market in 2025 benefits from strong global demand due to its essential role in preventing blood clotting in various medical treatments. Its widespread use in surgeries, dialysis, and blood transfusions is a key strength. Additionally, the increasing awareness of its therapeutic benefits and its low cost compared to other anticoagulants will support its market growth.
What are the weaknesses of the crude heparin market in 2025?
A significant weakness is the reliance on animal-derived sources, particularly from pig intestines, which raises concerns over supply chain stability and ethical considerations. There is also a risk of contamination and quality control issues. The market’s dependence on a few key suppliers makes it vulnerable to disruptions.
What opportunities exist for the crude heparin market in 2025?
Opportunities lie in the continued growth of the global healthcare industry, especially in emerging markets where demand for affordable anticoagulants is rising. Advancements in production technologies, such as the development of synthetic alternatives or innovations in heparin extraction methods, present new growth avenues. Furthermore, expanding the application of heparin in non-clinical areas could provide additional revenue streams.
What threats does the crude heparin market face in 2025?
The crude heparin market faces regulatory pressures and potential price volatility due to changing environmental and health regulations, as well as geopolitical factors impacting supply chains. The emergence of alternative anticoagulants and synthetic products that could reduce the reliance on crude heparin may also pose a threat to market stability.
Market PESTEL Analysis
What are the political factors influencing the crude heparin market in 2025?
Political factors such as government regulations on animal-derived products, trade policies, and import-export restrictions can significantly impact the crude heparin market. Policies surrounding the ethical sourcing of raw materials, as well as healthcare regulations on drug safety, are essential in shaping the market's dynamics.
How do economic factors affect the crude heparin market in 2025?
Economic conditions, including healthcare spending and the affordability of crude heparin, directly influence the market. In times of economic downturn, cost-effective alternatives like heparin are likely to see increased demand. Additionally, the growing focus on affordable healthcare in emerging economies can drive market expansion.
What are the social factors impacting the crude heparin market in 2025?
Social factors include the rising awareness of the therapeutic benefits of heparin and the increasing number of surgeries and chronic conditions requiring anticoagulation therapy. However, concerns about animal welfare and the sustainability of heparin production could lead to growing demand for ethical and synthetic alternatives.
How do technological factors influence the crude heparin market in 2025?
Technological advancements in biotechnology and synthetic drug development are changing the landscape of the crude heparin market. Innovations in extraction methods, quality control, and synthetic heparin alternatives may disrupt the current market, creating competition and improving production efficiency.
What environmental factors affect the crude heparin market in 2025?
Environmental concerns related to animal farming and the extraction of heparin from animal sources could lead to stricter regulations or a shift towards more sustainable production practices. Additionally, climate change could impact the availability of raw materials, affecting supply chains.
How do legal factors impact the crude heparin market in 2025?
Legal factors include stringent regulations on drug production, quality standards, and animal welfare laws. The crude heparin market is also subject to intellectual property laws, which may influence the development of new synthetic alternatives and the pricing strategies of suppliers.
Market SIPOC Analysis
Who are the suppliers in the crude heparin market in 2025?
Suppliers in the crude heparin market primarily include livestock farms (especially pig farms), pharmaceutical manufacturers, and specialized heparin extraction facilities. These suppliers provide the raw materials and production expertise required for heparin manufacturing.
What are the inputs in the crude heparin market in 2025?
Inputs consist of raw heparin from animal sources, processing technologies, skilled labor, regulatory compliance resources, and distribution networks. These elements are essential for the extraction, production, and delivery of crude heparin to the market.
What are the processes involved in the crude heparin market in 2025?
The key processes include the extraction of heparin from animal tissue, quality control to ensure safety and efficacy, regulatory compliance and documentation, and packaging for distribution. This is followed by distribution through pharmaceutical companies to hospitals, clinics, and pharmacies.
Who are the customers in the crude heparin market in 2025?
Customers in the crude heparin market include pharmaceutical companies, hospitals, clinics, dialysis centers, and other healthcare providers that use heparin for therapeutic purposes. Additionally, governments and health organizations involved in providing affordable anticoagulants to patients are key customers.
What are the outputs of the crude heparin market in 2025?
The primary output is crude heparin, which is used in medical treatments such as anticoagulation therapy for surgery, dialysis, and blood clots. Other outputs include refined heparin products, derived from crude heparin, and byproducts used in alternative applications.
Market Porter's Five Forces
How intense is the threat of new entrants in the crude heparin market in 2025?
The threat of new entrants is moderate due to high barriers to entry, including the need for specialized knowledge, access to animal sources, compliance with stringent regulatory standards, and established supply chains. New entrants may struggle to compete with existing, well-established players.
What is the bargaining power of suppliers in the crude heparin market in 2025?
The bargaining power of suppliers is high, as the market relies on a limited number of suppliers for raw materials, particularly from animal sources like pigs. Any disruption in supply or ethical concerns regarding sourcing can significantly affect pricing and availability.
What is the bargaining power of buyers in the crude heparin market in 2025?
The bargaining power of buyers is moderate. Large pharmaceutical companies and healthcare providers may have some leverage in negotiating prices due to bulk purchases. However, the lack of readily available substitutes for crude heparin in certain therapeutic areas limits buyer power.
How intense is the threat of substitute products in the crude heparin market in 2025?
The threat of substitutes is moderate to high. Alternatives such as synthetic heparin and newer anticoagulants are emerging, but they are often more expensive or not as widely used in certain markets, making crude heparin still the preferred option in many healthcare settings.
How competitive is the crude heparin market in 2025?
The competition in the crude heparin market is moderate. While a few large pharmaceutical companies dominate the market, there is still competition within the industry, particularly in terms of price and quality. Regulatory constraints and limited suppliers, however, somewhat reduce the level of competition.
Market Upstream Analysis
What are the key upstream factors affecting the crude heparin market in 2025?
Key upstream factors include the availability and cost of raw materials, primarily derived from animal sources such as pig intestines. Ethical considerations and sustainability practices in sourcing also play a significant role. Additionally, regulatory requirements for animal health and safety in the extraction process can impact the supply chain.
How does the supply of raw materials influence the crude heparin market in 2025?
The supply of raw materials is critical as it directly affects the production of crude heparin. Variations in animal farming practices, disease outbreaks affecting livestock, or disruptions in the supply chain can lead to fluctuations in availability and cost, influencing the overall market dynamics.
What role do upstream suppliers play in the crude heparin market in 2025?
Upstream suppliers, such as animal farms and heparin extraction facilities, are crucial in providing the raw materials and intermediate products necessary for heparin production. Their ability to maintain consistent quality, meet regulatory standards, and manage supply chain risks is essential for the stability of the market.
How do technological advancements impact upstream operations in the crude heparin market?
Technological advancements in biotechnology and heparin extraction processes have the potential to improve efficiency and reduce costs in upstream operations. New technologies may also allow for the development of synthetic or alternative sources of heparin, which could disrupt traditional raw material sourcing and production methods.
What regulatory factors affect upstream operations in the crude heparin market?
Regulations surrounding animal welfare, environmental impact, and product safety standards are major upstream considerations. Compliance with these regulations ensures the ethical and safe sourcing of raw materials, impacting production costs and supply reliability.
Market Midstream Analysis
What are the key midstream factors affecting the crude heparin market in 2025?
Key midstream factors include the processing and refinement of crude heparin, quality control measures, and regulatory compliance. This stage also involves packaging and preparing heparin for distribution to pharmaceutical companies and healthcare providers. Efficient and safe processing is critical to ensuring high-quality products.
How does the processing of crude heparin impact the market in 2025?
The processing of crude heparin is a critical stage that determines the quality and efficacy of the final product. Any inefficiencies or contamination risks during this stage can lead to product recalls, regulatory penalties, or loss of market trust. Advances in processing technology may help streamline operations and reduce costs.
What role do midstream players have in the crude heparin market in 2025?
Midstream players, such as heparin refineries and manufacturers, are essential in converting raw heparin into usable pharmaceutical-grade products. They are responsible for adhering to strict regulatory standards and ensuring that the end product meets the required safety and efficacy standards for medical use.
How do regulatory requirements impact midstream operations in the crude heparin market?
Regulatory requirements have a significant impact on midstream operations by dictating how crude heparin is processed, tested, and packaged. Compliance with these regulations ensures that products are safe for medical use and can be marketed globally. Non-compliance could result in fines, delays, or market withdrawals.
What technological advancements are influencing midstream operations in the crude heparin market?
Technological advancements, such as automation in heparin extraction, improved purification techniques, and enhanced quality control processes, are transforming midstream operations. These innovations can help reduce costs, improve product consistency, and ensure faster time-to-market for heparin-based products.
Market Downstream Analysis
What are the key downstream factors affecting the crude heparin market in 2025?
Key downstream factors include distribution channels, customer demand from healthcare providers, and market access to various regions. The final delivery of crude heparin to hospitals, clinics, and pharmaceutical companies is also influenced by logistics and regulatory approval processes in different markets.
How does demand from healthcare providers impact the crude heparin market in 2025?
Healthcare providers' demand for crude heparin is driven by the increasing prevalence of conditions requiring anticoagulation therapy, such as cardiovascular diseases and surgeries. As more hospitals adopt heparin for medical treatments, the downstream market is expected to grow, particularly in emerging markets where affordable treatment options are essential.
What role do downstream distributors play in the crude heparin market in 2025?
Downstream distributors ensure that crude heparin reaches healthcare providers and pharmaceutical companies efficiently. They manage inventory, distribution networks, and often have to navigate regional regulatory requirements to ensure smooth delivery and availability across diverse markets.
How do regulatory approval and market access impact downstream operations in the crude heparin market?
Regulatory approval and market access are crucial for the distribution and commercialization of crude heparin. Local health regulations and the approval processes in different regions can delay or restrict access, impacting the ability to supply crude heparin consistently. Compliance with these regulations ensures safety and efficacy, thus fostering trust in the product.
What technological advancements influence downstream operations in the crude heparin market?
Technological advancements in logistics, such as improved tracking systems, automated inventory management, and cold chain technology, are enhancing downstream operations. These innovations help ensure that crude heparin is delivered safely, efficiently, and on time, while reducing the risk of stockouts or product degradation.
Chapter 1, to describe Crude Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Crude Heparin, with price, sales, revenue and global market share of Crude Heparin from 2018 to 2023.
Chapter 3, the Crude Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crude Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Crude Heparin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Crude Heparin.
Chapter 14 and 15, to describe Crude Heparin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Crude Heparin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Crude Heparin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pig Intestine Mucosa Heparin
1.3.3 Bovine Heparin and Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Crude Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 UFH
1.4.3 LMWH
1.5 Global Crude Heparin Market Size & Forecast
1.5.1 Global Crude Heparin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Crude Heparin Sales Quantity (2018-2029)
1.5.3 Global Crude Heparin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bioiberica
2.1.1 Bioiberica Details
2.1.2 Bioiberica Major Business
2.1.3 Bioiberica Crude Heparin Product and Services
2.1.4 Bioiberica Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bioiberica Recent Developments/Updates
2.2 Shenzhen Hepalink
2.2.1 Shenzhen Hepalink Details
2.2.2 Shenzhen Hepalink Major Business
2.2.3 Shenzhen Hepalink Crude Heparin Product and Services
2.2.4 Shenzhen Hepalink Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shenzhen Hepalink Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Crude Heparin Product and Services
2.3.4 Sanofi Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Nanjing King-friend
2.4.1 Nanjing King-friend Details
2.4.2 Nanjing King-friend Major Business
2.4.3 Nanjing King-friend Crude Heparin Product and Services
2.4.4 Nanjing King-friend Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nanjing King-friend Recent Developments/Updates
2.5 Fengrun Biological Technology
2.5.1 Fengrun Biological Technology Details
2.5.2 Fengrun Biological Technology Major Business
2.5.3 Fengrun Biological Technology Crude Heparin Product and Services
2.5.4 Fengrun Biological Technology Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fengrun Biological Technology Recent Developments/Updates
2.6 Aspen Oss
2.6.1 Aspen Oss Details
2.6.2 Aspen Oss Major Business
2.6.3 Aspen Oss Crude Heparin Product and Services
2.6.4 Aspen Oss Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aspen Oss Recent Developments/Updates
2.7 Hebei Changshan Biochemical
2.7.1 Hebei Changshan Biochemical Details
2.7.2 Hebei Changshan Biochemical Major Business
2.7.3 Hebei Changshan Biochemical Crude Heparin Product and Services
2.7.4 Hebei Changshan Biochemical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hebei Changshan Biochemical Recent Developments/Updates
2.8 Changzhou Qianhong
2.8.1 Changzhou Qianhong Details
2.8.2 Changzhou Qianhong Major Business
2.8.3 Changzhou Qianhong Crude Heparin Product and Services
2.8.4 Changzhou Qianhong Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changzhou Qianhong Recent Developments/Updates
2.9 Hepac (Darling Ingredients)
2.9.1 Hepac (Darling Ingredients) Details
2.9.2 Hepac (Darling Ingredients) Major Business
2.9.3 Hepac (Darling Ingredients) Crude Heparin Product and Services
2.9.4 Hepac (Darling Ingredients) Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
2.10 Huaian MDC Pharmaceutical
2.10.1 Huaian MDC Pharmaceutical Details
2.10.2 Huaian MDC Pharmaceutical Major Business
2.10.3 Huaian MDC Pharmaceutical Crude Heparin Product and Services
2.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
2.11 Yantai Dongcheng Biochemicals
2.11.1 Yantai Dongcheng Biochemicals Details
2.11.2 Yantai Dongcheng Biochemicals Major Business
2.11.3 Yantai Dongcheng Biochemicals Crude Heparin Product and Services
2.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates
3 Competitive Environment: Crude Heparin by Manufacturer
3.1 Global Crude Heparin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Crude Heparin Revenue by Manufacturer (2018-2023)
3.3 Global Crude Heparin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Crude Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Crude Heparin Manufacturer Market Share in 2022
3.4.2 Top 6 Crude Heparin Manufacturer Market Share in 2022
3.5 Crude Heparin Market: Overall Company Footprint Analysis
3.5.1 Crude Heparin Market: Region Footprint
3.5.2 Crude Heparin Market: Company Product Type Footprint
3.5.3 Crude Heparin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Crude Heparin Market Size by Region
4.1.1 Global Crude Heparin Sales Quantity by Region (2018-2029)
4.1.2 Global Crude Heparin Consumption Value by Region (2018-2029)
4.1.3 Global Crude Heparin Average Price by Region (2018-2029)
4.2 North America Crude Heparin Consumption Value (2018-2029)
4.3 Europe Crude Heparin Consumption Value (2018-2029)
4.4 Asia-Pacific Crude Heparin Consumption Value (2018-2029)
4.5 South America Crude Heparin Consumption Value (2018-2029)
4.6 Middle East and Africa Crude Heparin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Crude Heparin Sales Quantity by Type (2018-2029)
5.2 Global Crude Heparin Consumption Value by Type (2018-2029)
5.3 Global Crude Heparin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Crude Heparin Sales Quantity by Application (2018-2029)
6.2 Global Crude Heparin Consumption Value by Application (2018-2029)
6.3 Global Crude Heparin Average Price by Application (2018-2029)
7 North America
7.1 North America Crude Heparin Sales Quantity by Type (2018-2029)
7.2 North America Crude Heparin Sales Quantity by Application (2018-2029)
7.3 North America Crude Heparin Market Size by Country
7.3.1 North America Crude Heparin Sales Quantity by Country (2018-2029)
7.3.2 North America Crude Heparin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Crude Heparin Sales Quantity by Type (2018-2029)
8.2 Europe Crude Heparin Sales Quantity by Application (2018-2029)
8.3 Europe Crude Heparin Market Size by Country
8.3.1 Europe Crude Heparin Sales Quantity by Country (2018-2029)
8.3.2 Europe Crude Heparin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Crude Heparin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Crude Heparin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Crude Heparin Market Size by Region
9.3.1 Asia-Pacific Crude Heparin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Crude Heparin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Crude Heparin Sales Quantity by Type (2018-2029)
10.2 South America Crude Heparin Sales Quantity by Application (2018-2029)
10.3 South America Crude Heparin Market Size by Country
10.3.1 South America Crude Heparin Sales Quantity by Country (2018-2029)
10.3.2 South America Crude Heparin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Crude Heparin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Crude Heparin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Crude Heparin Market Size by Country
11.3.1 Middle East & Africa Crude Heparin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Crude Heparin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Crude Heparin Market Drivers
12.2 Crude Heparin Market Restraints
12.3 Crude Heparin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Crude Heparin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Crude Heparin
13.3 Crude Heparin Production Process
13.4 Crude Heparin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Crude Heparin Typical Distributors
14.3 Crude Heparin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Crude Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Crude Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bioiberica Basic Information, Manufacturing Base and Competitors
Table 4. Bioiberica Major Business
Table 5. Bioiberica Crude Heparin Product and Services
Table 6. Bioiberica Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bioiberica Recent Developments/Updates
Table 8. Shenzhen Hepalink Basic Information, Manufacturing Base and Competitors
Table 9. Shenzhen Hepalink Major Business
Table 10. Shenzhen Hepalink Crude Heparin Product and Services
Table 11. Shenzhen Hepalink Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Shenzhen Hepalink Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Crude Heparin Product and Services
Table 16. Sanofi Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Nanjing King-friend Basic Information, Manufacturing Base and Competitors
Table 19. Nanjing King-friend Major Business
Table 20. Nanjing King-friend Crude Heparin Product and Services
Table 21. Nanjing King-friend Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Nanjing King-friend Recent Developments/Updates
Table 23. Fengrun Biological Technology Basic Information, Manufacturing Base and Competitors
Table 24. Fengrun Biological Technology Major Business
Table 25. Fengrun Biological Technology Crude Heparin Product and Services
Table 26. Fengrun Biological Technology Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Fengrun Biological Technology Recent Developments/Updates
Table 28. Aspen Oss Basic Information, Manufacturing Base and Competitors
Table 29. Aspen Oss Major Business
Table 30. Aspen Oss Crude Heparin Product and Services
Table 31. Aspen Oss Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aspen Oss Recent Developments/Updates
Table 33. Hebei Changshan Biochemical Basic Information, Manufacturing Base and Competitors
Table 34. Hebei Changshan Biochemical Major Business
Table 35. Hebei Changshan Biochemical Crude Heparin Product and Services
Table 36. Hebei Changshan Biochemical Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hebei Changshan Biochemical Recent Developments/Updates
Table 38. Changzhou Qianhong Basic Information, Manufacturing Base and Competitors
Table 39. Changzhou Qianhong Major Business
Table 40. Changzhou Qianhong Crude Heparin Product and Services
Table 41. Changzhou Qianhong Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Changzhou Qianhong Recent Developments/Updates
Table 43. Hepac (Darling Ingredients) Basic Information, Manufacturing Base and Competitors
Table 44. Hepac (Darling Ingredients) Major Business
Table 45. Hepac (Darling Ingredients) Crude Heparin Product and Services
Table 46. Hepac (Darling Ingredients) Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hepac (Darling Ingredients) Recent Developments/Updates
Table 48. Huaian MDC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Huaian MDC Pharmaceutical Major Business
Table 50. Huaian MDC Pharmaceutical Crude Heparin Product and Services
Table 51. Huaian MDC Pharmaceutical Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Huaian MDC Pharmaceutical Recent Developments/Updates
Table 53. Yantai Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
Table 54. Yantai Dongcheng Biochemicals Major Business
Table 55. Yantai Dongcheng Biochemicals Crude Heparin Product and Services
Table 56. Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Yantai Dongcheng Biochemicals Recent Developments/Updates
Table 58. Global Crude Heparin Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 59. Global Crude Heparin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Crude Heparin Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 61. Market Position of Manufacturers in Crude Heparin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Crude Heparin Production Site of Key Manufacturer
Table 63. Crude Heparin Market: Company Product Type Footprint
Table 64. Crude Heparin Market: Company Product Application Footprint
Table 65. Crude Heparin New Market Entrants and Barriers to Market Entry
Table 66. Crude Heparin Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Crude Heparin Sales Quantity by Region (2018-2023) & (Tons)
Table 68. Global Crude Heparin Sales Quantity by Region (2024-2029) & (Tons)
Table 69. Global Crude Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Crude Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Crude Heparin Average Price by Region (2018-2023) & (US$/Kg)
Table 72. Global Crude Heparin Average Price by Region (2024-2029) & (US$/Kg)
Table 73. Global Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 74. Global Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 75. Global Crude Heparin Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Crude Heparin Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Crude Heparin Average Price by Type (2018-2023) & (US$/Kg)
Table 78. Global Crude Heparin Average Price by Type (2024-2029) & (US$/Kg)
Table 79. Global Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 80. Global Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 81. Global Crude Heparin Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Crude Heparin Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Crude Heparin Average Price by Application (2018-2023) & (US$/Kg)
Table 84. Global Crude Heparin Average Price by Application (2024-2029) & (US$/Kg)
Table 85. North America Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 86. North America Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 87. North America Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 88. North America Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 89. North America Crude Heparin Sales Quantity by Country (2018-2023) & (Tons)
Table 90. North America Crude Heparin Sales Quantity by Country (2024-2029) & (Tons)
Table 91. North America Crude Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Crude Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 94. Europe Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 95. Europe Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 96. Europe Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 97. Europe Crude Heparin Sales Quantity by Country (2018-2023) & (Tons)
Table 98. Europe Crude Heparin Sales Quantity by Country (2024-2029) & (Tons)
Table 99. Europe Crude Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Crude Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 102. Asia-Pacific Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 103. Asia-Pacific Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 104. Asia-Pacific Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 105. Asia-Pacific Crude Heparin Sales Quantity by Region (2018-2023) & (Tons)
Table 106. Asia-Pacific Crude Heparin Sales Quantity by Region (2024-2029) & (Tons)
Table 107. Asia-Pacific Crude Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Crude Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 110. South America Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 111. South America Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 112. South America Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 113. South America Crude Heparin Sales Quantity by Country (2018-2023) & (Tons)
Table 114. South America Crude Heparin Sales Quantity by Country (2024-2029) & (Tons)
Table 115. South America Crude Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Crude Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Crude Heparin Sales Quantity by Type (2018-2023) & (Tons)
Table 118. Middle East & Africa Crude Heparin Sales Quantity by Type (2024-2029) & (Tons)
Table 119. Middle East & Africa Crude Heparin Sales Quantity by Application (2018-2023) & (Tons)
Table 120. Middle East & Africa Crude Heparin Sales Quantity by Application (2024-2029) & (Tons)
Table 121. Middle East & Africa Crude Heparin Sales Quantity by Region (2018-2023) & (Tons)
Table 122. Middle East & Africa Crude Heparin Sales Quantity by Region (2024-2029) & (Tons)
Table 123. Middle East & Africa Crude Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Crude Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Crude Heparin Raw Material
Table 126. Key Manufacturers of Crude Heparin Raw Materials
Table 127. Crude Heparin Typical Distributors
Table 128. Crude Heparin Typical Customers
List of Figures
Figure 1. Crude Heparin Picture
Figure 2. Global Crude Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Crude Heparin Consumption Value Market Share by Type in 2022
Figure 4. Pig Intestine Mucosa Heparin Examples
Figure 5. Bovine Heparin and Others Examples
Figure 6. Global Crude Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Crude Heparin Consumption Value Market Share by Application in 2022
Figure 8. UFH Examples
Figure 9. LMWH Examples
Figure 10. Global Crude Heparin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Crude Heparin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Crude Heparin Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Crude Heparin Average Price (2018-2029) & (US$/Kg)
Figure 14. Global Crude Heparin Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Crude Heparin Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Crude Heparin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Crude Heparin Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Crude Heparin Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Crude Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Crude Heparin Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Crude Heparin Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Crude Heparin Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Crude Heparin Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Crude Heparin Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Crude Heparin Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Crude Heparin Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Crude Heparin Average Price by Type (2018-2029) & (US$/Kg)
Figure 29. Global Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Crude Heparin Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Crude Heparin Average Price by Application (2018-2029) & (US$/Kg)
Figure 32. North America Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Crude Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Crude Heparin Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Crude Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Crude Heparin Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Crude Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Crude Heparin Consumption Value Market Share by Region (2018-2029)
Figure 52. China Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Crude Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Crude Heparin Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Crude Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Crude Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Crude Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Crude Heparin Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Crude Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Crude Heparin Market Drivers
Figure 73. Crude Heparin Market Restraints
Figure 74. Crude Heparin Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Crude Heparin in 2022
Figure 77. Manufacturing Process Analysis of Crude Heparin
Figure 78. Crude Heparin Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
